VWR Corp (NASDAQ:VWR) Sees Significant Increase in Short Interest

VWR Corp (NASDAQ:VWR) saw a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 957,513 shares, an increase of 51.9% from the October 31st total of 630,542 shares. Based on an average daily volume of 723,291 shares, the short-interest ratio is presently 1.3 days.

Shares of VWR (NASDAQ:VWR) opened at $33.25 on Wednesday. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.25 and a quick ratio of 0.79. VWR has a 12-month low of $24.42 and a 12-month high of $37.25. The stock has a market capitalization of $4,380.00 and a price-to-earnings ratio of 17.32.

VWR (NASDAQ:VWR) last released its earnings results on Tuesday, November 7th. The medical research company reported $0.54 EPS for the quarter, beating the Zacks’ consensus estimate of $0.46 by $0.08. VWR had a return on equity of 11.79% and a net margin of 4.11%. The business had revenue of $1.20 billion for the quarter, compared to analysts’ expectations of $1.16 billion. During the same quarter in the prior year, the firm earned $0.44 earnings per share. The firm’s revenue was up 5.2% on a year-over-year basis. analysts expect that VWR will post 1.85 EPS for the current fiscal year.

A number of research analysts have recently issued reports on VWR shares. Zacks Investment Research raised VWR from a “hold” rating to a “buy” rating and set a $37.00 price objective on the stock in a research note on Tuesday, September 12th. BidaskClub lowered VWR from a “sell” rating to a “strong sell” rating in a report on Saturday, September 2nd. Finally, ValuEngine upgraded VWR from a “hold” rating to a “buy” rating in a research note on Tuesday, November 7th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. VWR presently has a consensus rating of “Hold” and a consensus target price of $31.67.

Several large investors have recently made changes to their positions in the company. Schroder Investment Management Group boosted its holdings in shares of VWR by 0.6% during the third quarter. Schroder Investment Management Group now owns 2,987,927 shares of the medical research company’s stock worth $98,871,000 after purchasing an additional 18,316 shares during the period. State Street Corp lifted its holdings in VWR by 6.9% in the first quarter. State Street Corp now owns 1,087,711 shares of the medical research company’s stock worth $30,676,000 after buying an additional 70,106 shares during the period. SG Americas Securities LLC lifted its holdings in VWR by 1,089.9% in the third quarter. SG Americas Securities LLC now owns 191,283 shares of the medical research company’s stock worth $6,333,000 after buying an additional 175,208 shares during the period. Colony Group LLC lifted its holdings in VWR by 6.5% in the second quarter. Colony Group LLC now owns 144,191 shares of the medical research company’s stock worth $4,760,000 after buying an additional 8,835 shares during the period. Finally, Aperio Group LLC lifted its holdings in VWR by 7.5% in the third quarter. Aperio Group LLC now owns 53,329 shares of the medical research company’s stock worth $1,766,000 after buying an additional 3,721 shares during the period. 96.66% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “VWR Corp (NASDAQ:VWR) Sees Significant Increase in Short Interest” was published by Week Herald and is owned by of Week Herald. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at https://weekherald.com/2017/12/13/vwr-corporation-vwr-short-interest-up-51-9-in-november.html.

VWR Company Profile

VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.

Receive News & Ratings for VWR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply